SAN DIEGO, June 23, Jun 23, 2021 (GLOBE NEWSWIRE via COMTEX) --
SAN DIEGO, June 23, 2021 (GLOBE NEWSWIRE) -- Shareholder Rights Law Firm Johnson Fistel, LLP, is investigating potential claims against Cloopen Group Holding Limited ("Cloopen" or the "Company")
for violations of federal securities laws.
On or about February 9, 2021, Cloopen sold about 20 million shares of stock in its initial public stock offering (the "IPO") at $16 a share, raising nearly $320 million in new capital. Since the IPO the stock has plummeted, closing at $7.81 on June 23, 2021,
Specifically, Johnson Fistel's investigation seeks to determine whether the Company's filings with the U.S. Securities and Exchange Commission in connection with its February 2021 IPO and subsequent investor communications contained untrue statements of material facts or omitted to state other facts necessary to make the statements made therein not misleading concerning the Company's business, and operations.
If you have information that could assist in this investigation, or if you are a Cloopen shareholder and are interested in learning more about the investigation, please contact Jim Baker ( email@example.com ) at 619-814-4471. If emailing, please include a phone number.
Additionally, you can [Click here to join this action]. There is no cost or obligation to you.
About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com . Attorney advertising. Past results do not guarantee future outcomes.
Johnson Fistel, LLP
Jim Baker, 619-814-4471
Is there a problem with this press release? Contact the source provider Comtex at firstname.lastname@example.org. You can also contact MarketWatch Customer Service via our Customer Center.
(C) Copyright 2021 GlobeNewswire, Inc. All rights reserved.